Neil Stahl, EVP Research and Development at REGENERON PHARMACEUTICALS INC (REGN), sold 1,812 shares at $482.56 ($873K) on 2017-06-02, disclosed to the SEC on 2017-06-05.
Open-market sale of $873k REGN by EVP Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $480.71 | 309 | $149K | 17.0% |
| 2 | $481.64 | 695 | $335K | 38.3% |
| 3 | $482.56 | 808 | $390K | 44.7% |
| Total | $481.89 avg | 1,812 | $873K | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |